Table 5.
Anaysis of risk factors related to delayed bleeding after ESD
| Delayed bleeding group (n = 11) | Non-delayed bleeding group (n = 448) | P value | |
|---|---|---|---|
| Age (year.mean ± SD) |
64.9 ± 12.7 |
71.6 ± 8.6 |
0.013 |
| Gender Man/Woman |
8 (72.7%)/3 (27.3%) |
336 (75.0%)/112 (25.0%) |
>0.999 (NS) |
| Tumor location |
|
|
|
| U |
1 (9.1%) |
74 (16.5%) |
>0.999 (NS) |
| M |
4 (36.4%) |
175 (39.1%) |
>0.999 (NS) |
| L |
6 (54.5%) |
199 (44.4%) |
0.551 (NS) |
| Macroscopic type |
|
|
|
| Elevated type/Depressed type |
7 (63.6%)/4 (36.4%) |
249 (55.6%)/199 (44.4%) |
0.762 (NS) |
| Size of resected specimen |
|
|
|
| (mm, mean ± SD) |
39.2 ± 16.1 |
40.4 ± 15.3 |
0.800 (NS) |
| Tumor size |
|
|
|
| (mm, mean ± SD) |
16.5 ± 12.2 |
17.3 ± 11.0 |
0.832 (NS) |
| Histopathology |
|
|
|
| Adenoma/Carcinoma |
2 (18.2%)/9 (81.8%) |
71 (15.8%)/377 (84.2%) |
0.690 (NS) |
| Depth of invasion |
|
|
|
| M/SM |
11 (100%)/0 (0.0%) |
412 (92.0%)/36 (8.0%) |
>0.999 (NS) |
| Ulcerative findings |
|
|
|
| None/present |
9 (81.8%)/2 (18.2%) |
417 (93.1%)/31 (6.9%) |
0.184 (NS) |
| Resected style |
|
|
|
| One-piece/Piecemeal |
11 (100%)/0 (0%) |
435 (97.1%)/13 (2.9%) |
>0.999 (NS) |
| Heart disease |
1 (9.1%) |
71 (15.8%) |
>0.999 (NS) |
| Renal disease |
3 (27.3%) |
18 (4.0%) |
0.011 |
| Hepatic disease |
1 (9.1%) |
44 (9.8%) |
>0.999 (NS) |
| Pulmonary disease |
1 (9.1%) |
35 (7.8%) |
0.597 (NS) |
| Brain disease |
0 (0%) |
45 (10.0%) |
0.611 (NS) |
| Hypertension |
6 (54.5%) |
203 (45.3%) |
0.763 (NS) |
| Diabetes mellitus |
3 (27.3%) |
72 (16.1%) |
0.399 (NS) |
| Hyperlipidemia | 1 (9.1%) | 66 (14.7%) | >0.999 (NS) |